BRIEF published on 02/16/2026 at 07:35, 8 months 10 days ago Nicox Receives Positive Feedback from FDA for NCX 470 NDA FDA Nicox Glaucoma Treatment NCX 470 NDA Submission
PRESS RELEASE published on 02/16/2026 at 07:30, 8 months 10 days ago Nicox annonce une réunion pré-NDA positive avec la FDA américaine pour NCX 470 Nicox annonce une réunion pré-NDA positive avec la FDA américaine pour NCX 470, confirmant le dépôt de la NDA pour l'été 2026. Collaboration avec Kowa et avancée vers l'autorisation de mise sur le marché FDA Nicox NCX 470 Réunion Pré-NDA Autorisation De Marché
PRESS RELEASE published on 02/16/2026 at 07:30, 8 months 10 days ago Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470 Nicox receives positive feedback from pre-NDA meeting with U.S. FDA for NCX 470, on track for NDA submission in summer 2026. NCX 470 lowers intraocular pressure in glaucoma patients FDA Nicox NCX 470 Intraocular Pressure Pre-NDA
BRIEF published on 02/12/2026 at 07:35, 8 months 14 days ago Nicox maintains its PEA-PME status for 2026 PEA-PME Euronext Growth Paris Investment Ophthalmology Nicox
BRIEF published on 02/12/2026 at 07:35, 8 months 14 days ago Nicox maintient son statut PEA-PME pour 2026 PEA-PME Euronext Growth Paris Investissement Ophtalmologie Nicox
PRESS RELEASE published on 02/12/2026 at 07:30, 8 months 14 days ago Nicox confirme son éligibilité au PEA-PME Nicox confirme son éligibilité au PEA-PME pour l'année à venir, permettant aux investisseurs de continuer à intégrer ses actions dans les comptes PEA PME PEA-PME Investissement Fiscalité Ophtalmologie Nicox
BRIEF published on 02/10/2026 at 07:35, 8 months 16 days ago Nicox to Present Key Data at AGS Annual Meeting 2026 Clinical Trials Glaucoma Nicox NCX 470 AGS 2026
BRIEF published on 02/10/2026 at 07:35, 8 months 16 days ago Nicox présentera des données clés lors de la réunion annuelle de l'AGS en 2026. Essais Cliniques Nicox NCX 470 Glaucome AGS 2026
PRESS RELEASE published on 02/10/2026 at 07:30, 8 months 16 days ago Nicox : Présentation des données des études de Phase 3 de NCX 470 au congrès annuel 2026 de l’American Glaucoma Society (AGS) Nicox présente les données des études de Phase 3 de NCX 470 au congrès annuel 2026 de l'AGS, démontrant l'efficacité de leur nouveau produit pour le glaucome Ophtalmologie Nicox NCX 470 Études De Phase 3 Congrès AGS
PRESS RELEASE published on 02/10/2026 at 07:30, 8 months 16 days ago Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026 Nicox to present NCX 470 Phase 3 data at AGS Annual Meeting 2026 with podium presentations showcasing clinical study results and efficacy of the ophthalmic solution Clinical Study Ophthalmology Nicox NCX 470 AGS Annual Meeting 2026
Published on 10/27/2026 at 01:00, 6 hours 16 minutes ago Mining Exploration Entity or Oil and Gas Exploration Entity Quarterly Cash Flow Report
Published on 10/27/2026 at 00:10, 7 hours 6 minutes ago Trans Canada Gold Closes Final Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,205,737 and Prepares for Phase 2 Drilling
Published on 10/26/2026 at 23:30, 7 hours 46 minutes ago Trans Canada Gold Closes Final Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,205,737 and Prepares for Phase 2 Drilling
Published on 10/26/2026 at 23:00, 8 hours 16 minutes ago American Hotel Income Properties REIT LP to Host Third Quarter 2026 Results Conference Call on November 16, 2026
Published on 10/26/2026 at 22:00, 9 hours 16 minutes ago IBC Advanced Alloys Announces Issuance of Share-Based Compensation to Directors
Published on 10/27/2026 at 07:00, 16 minutes ago INFICON reports record third quarter 2026 and raises full-year guidance
Published on 10/27/2026 at 07:00, 16 minutes ago REINET INVESTMENTS S.C.A. SHARE BUYBACK PROGRAMME – UPDATE 27 October 2026
Published on 10/27/2026 at 07:00, 16 minutes ago SIG Group AG: SIG delivers solid growth and higher profitability, and raises full-year margin guidance
Published on 10/27/2026 at 07:00, 16 minutes ago SIG Group AG: SIG outlines roadmap to accelerate profitable growth, expand margins and increase shareholder returns
Published on 10/26/2026 at 18:11, 13 hours 5 minutes ago Declaration of transactions on own shares from October 19, 2026 to October 25, 2026
Published on 10/26/2026 at 18:11, 13 hours 5 minutes ago Déclaration des transactions sur actions propres réalisées du 19/10/2026 au 25/10/2026
Published on 10/26/2026 at 17:45, 13 hours 31 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 10/26/2026 at 17:45, 13 hours 31 minutes ago Infotel : Déclaration des transactions sur actions propres réalisées du 19 au 23 octobre 2026 dans le cadre du programme de rachat d’actions.
